What does CUSIP 92673K108 represent in this 13F holders report?

CUSIP 92673K108 is the security identifier for VIGL - Vigil Neuroscience, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VIGL - Vigil Neuroscience, Inc. - Common Stock in Q3 2024?

51 institutional investors reported VIGL - Vigil Neuroscience, Inc. - Common Stock for Q3 2024. Use the holders table for investor-level position and value details.

Vigil Neuroscience, Inc. - Common Stock (VIGL)

CUSIP: 92673K108

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock
Shares outstanding: 46,698,729
Total 13F shares: 27,719,278
Share change: -422,608
Total reported value: $94,246,371
Reported price per share: $3.40
Number of holders: 51
Value change: -$2,955,251
Number of buys: 20
Number of sells: 33

Security key

92673K108

Report period

Q3 2024

Institutions

Top holders

VIGL full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Vigil Neuroscience, Inc. SEC filings Vigil Neuroscience, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92673K108

Newer quarter: Q4 2024 Previous quarter: Q2 2024

Recent filing periods:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Ownership snapshot

Top reported holders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Atlas Venture Life Scienc...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2024

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Rank 1 holder

Atlas Venture Life Science Advisors, LLC

13F

Ownership: 12%
Position: $23.35M

13F

Rank 2 holder

Northpond Ventures, LLC

13F

Ownership: 9%
Position: $16.86M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Atlas Venture Life Science Advisors, LLC	13F Company 13F	12%	$23,347,496 5,836,874 shares	—	30 Jun 2024
Northpond Ventures, LLC	13F Company 13F	9%	$16,857,992 4,214,498 shares	—	30 Jun 2024
Artal Group S.A.	13F Company 13F	3.9%	$7,314,764 1,828,691 shares	—	30 Jun 2024
BVF INC/IL	13F Company 13F	3.9%	$7,254,532 1,813,633 shares	—	30 Jun 2024
SPHERA FUNDS MANAGEMENT LTD.	13F Company 13F	3.6%	$6,768,664 1,692,166 shares	—	30 Jun 2024
Point72 Asset Management, L.P.	13F Company 13F	3.2%	$5,940,000 1,485,000 shares	—	30 Jun 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

27,719,278

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

-6

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend